Production (Stage)
Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
| 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
|---|---|---|---|---|---|
| Net Income | -289.70K | -255.20K | -4.45M | -298.90K | -603.40K |
| Total Depreciation and Amortization | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 |
| Total Amortization of Deferred Charges | 127.00K | 94.30K | -- | -- | 19.60K |
| Total Other Non-Cash Items | -- | -- | 3.59M | 149.70K | 282.10K |
| Change in Net Operating Assets | 14.20K | 9.80K | 839.00K | -40.40K | 92.60K |
| Cash from Operations | -148.30K | -150.90K | -26.90K | -189.30K | -208.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 250.00K | 106.90K | 0.00 | 213.60K | 250.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 250.00K | 106.90K | 0.00 | 213.60K | 250.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | -- |
| Net Change in Cash | 101.70K | -44.00K | -26.90K | 24.20K | 41.20K |